-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901.O1.6 901. Health Services Research—Non-Malignant Conditions I

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
sickle cell disease, Adult, Coronaviruses, SARS-CoV-2/COVID-19, Diseases, Therapies, Genetic Disorders, Pediatric, Hemoglobinopathies, Young Adult, Study Population, Clinically relevant, Quality Improvement
Saturday, December 5, 2020: 2:00 PM-3:30 PM
Moderators:
Staci D. Arnold, MD, MBA, MPH, Children's Healthcare of Atlanta/Emory University and Alina Sadaf, MD, Cincinnati Children's Hospital Medical Center
Disclosures:
No relevant conflicts of interest to declare.
2:00 PM
302
COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or TraitClinically Relevant Abstract

Ashima Singh, PhD, MS1, Amanda M. Brandow, DO, MS2,3,4 and Julie Panepinto, MD, MS5

1Medical College of WI, Milwaukee, WI
2Medical College of Wisconsin, Milwaukee, WI
3Pediatric Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
4Pediatric Hematology/Oncology, Medical College of Wisconsin and Children's Research Institute of the Children's Hospital of Wisconsin, Milwaukee, WI
5Pediatrics, Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, WI
2:15 PM
303
10-Year Mortality in Patients with Sickle Cell Disease from a Large Population-Based CohortClinically Relevant Abstract

Kristina Lai, MPH1*, Marianne McPherson Yee, MD, MSc2, Beatrice Gee, MD3, Maa-Ohui Quarmyne, MBChB MS4, Ross M. Fasano, MD5*, Alexander Maillis, MPH6* and Peter A. Lane, MD7

1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
2Children's Healthcare of Atlanta, Atlanta, GA
3Children's At Hughes Spalding, Atlanta, GA
4Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
5Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
6Aflac Cancer and Blood Disorders Service, Children's Healthcare of Atlanta, Atlanta, GA
7Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA
2:30 PM
304
Mobile Health Use Predicts Self-Efficacy and Self-Management in Adolescents with Sickle Cell Disease

Anna M Hood, PhD1*, Cara Nwankwo, BA2*, Emily McTate, PhD3*, Naomi E Joffe, PhD4*, Charles T. Quinn, MD5, James L Peugh, PhD6* and Lori E Crosby, PsyD7

1Great Ormond Street Institute of Child Health, University College London, Cincinnati, OH
2Oklahoma State University, Stillwater, OK
3Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH
4Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
6Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
7Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH
2:45 PM
305
Barriers and Facilitators of Advance Care Planning for Older Adults with Sickle Cell Disease

Charity I Oyedeji, MD1, Tolulpe Oyesanya, PhD, RN2*, Nathan Gray, MD3* and John J. Strouse, MD, PhD1

1Department of Medicine, Division of Hematology, Duke University School of Medicine, Durham, NC
2School of Nursing, Duke University, Durham, NC
3Duke Palliative Care, Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC
See more of: Oral and Poster Abstracts
<< Previous Session | Next Session >>
*signifies non-member of ASH